EcoDrugPlus

Selectin, Endothelial Cell

Ensembl ID : ENSPEMG00000019779
Gene Symbol: SELE
1 Cross references
197 Possible Orthologues:

Selectin, Lymphocyte

Ensembl ID : ENSPEMG00000015680
Gene Symbol: SELL
1 Cross references
86 Possible Orthologues:

Selectin, Platelet

Ensembl ID : ENSPEMG00000020102
Gene Symbol: SELP
1 Cross references
120 Possible Orthologues:

Serine (Or Cysteine) Peptidase Inhibitor, Clade C (Antithrombin), Member 1

Ensembl ID : ENSPEMG00000011148
Gene Symbol: SERPINC1
1 Cross references
199 Possible Orthologues:

Sigma Non-Opioid Intracellular Receptor 1

Ensembl ID : ENSPEMG00000027495
Gene Symbol: SIGMAR1
2 Cross references
203 Possible Orthologues:

Smoothened, Frizzled Class Receptor

Ensembl ID : ENSPEMG00000021296
Gene Symbol: SMO
3 Cross references
204 Possible Orthologues:

Sodium Channel Epithelial 1 Beta Subunit

Ensembl ID : ENSPEMG00000026124
Gene Symbol: SCNN1B
3 Cross references
151 Possible Orthologues:

Sodium Channel Epithelial 1 Gamma Subunit

Ensembl ID : ENSPEMG00000017098
Gene Symbol: SCNN1G
3 Cross references
155 Possible Orthologues:

Sodium Channel Protein Type 3 Subunit Alpha

Ensembl ID : ENSPEMG00000012012
Gene Symbol: LOC102919673
3 Cross references
167 Possible Orthologues:

Sodium Channel, Nonvoltage-Gated 1 Alpha

Ensembl ID : ENSPEMG00000012010
Gene Symbol: SCNN1A
1 Cross references
153 Possible Orthologues:

Sodium Channel, Voltage-Gated, Type I, Alpha

Ensembl ID : ENSPEMG00000019046
Gene Symbol: SCN1A
1 Cross references
139 Possible Orthologues:

Sodium Channel, Voltage-Gated, Type Ii, Alpha

Ensembl ID : ENSPEMG00000002426
Gene Symbol: SCN2A
1 Cross references
130 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).